The sentinal node: The Dijon experience;Le ganglion sentinelle: Une expérience Dijonnaise

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 31, Issue 6, 2002, Pages 565-571

  Hoyek, T ^a   Benoit, L ^a   Fraisse, J ^a  

^a NONE   (France)

Author keywords

Breast cancer; Lymphoscintigraphy; Patent blue dye; Sentinel node

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CENTER; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEASIBILITY STUDIES; FEMALE; FRANCE; GAMMA CAMERAS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHENIUM; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM;

EID: 0036807938     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ricard M, Bard JJ, Boneu A, et al. Radioprotection et détection peropératoire du ganglion sentinelle par colloïde marqué au Tc99m. Médecine Nucléaire-Imagerie Fonctionelle et Métabolique 1998; 22: 431-4.
2. Rodier JF, Routiot T, Mignotte H, et al. Individualisation du ganglion axillaire sentinelle par colorant lymphotrope dans les cancers du sein. Étude de faisabilité à propos de 128 cas. Chirurgie 1998; 123: 239-46.
3. Copeland EM. Is axillary dissection necessary for T1 carcinoma of the breast? J Am Coll Surg 1997; 187: 397-8.
4. Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: Is it required in T1a breast cancer? J Am Coll Surg 1997; 184: 493-8.
5. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997; 10: 1918-22.
6. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-22.
7. Pijpers R, Meijair S, Hoestra O, et al. Impact of lymphoscintigraphy on sentinel node identification with Tc99m colloïdal albumin in breast cancer. J Nucl Med 1997; 38: 366-8.
8. Mertz L, Mathelin C, Marin C, et al. Injection sous-aréolaire de sulfocolloïdes technétiés pour l'identification des ganglions sentinelles dans les cancers du sein invasifs à foyers multiples. Bull Cancer 1999; 86: 939-45.
9. Keshtgor MRS, Ell PJ. Sentinel lymph node detection imaging. European Journal of Nuclear Medicine 1999; 26: 57-67.
10. Gulec SA, Moffat FL, Carroll RG, et al. Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med 1997; 41: 251-61.
11. Spiegel M, Vesti B, Shore A, et al. Pressure of lymphatic capillaries in human skin. Am J Physiol 1992; 262: 1208-10.
12. Bougstein PO, Meijer S, Pijpers R. Intradermal blue dye identify sentinel lymph node in breast cancer. Lancet 1997; 349: 1668-9.
13. Pourquier D, Lemanski C, Faurous P, Couty H. Cancer du sein: Retour de la lymphoscintigraphie. Bull Cancer 1998; 85: 675-84.
14. Nos C, Bourgeois D, Freneaux P, et al. Individualisation de ganglion sentinelle en cas de cancer du sein: Expérience à l'Institut Curie. Bull Cancer 1999; 86: 580-4.
15. Rodier JF, Routiot T, Mignotte H, Janser JC, Bremond A, David E, et al. Lymphatic mapping and sentinel node biopsy of operable breast cancer. World J Surg 2000; 24: 1220-6.
16. McMasters KM. Sentinel lymph node biopsy for breast cancer. J Clin Oncol 2000; 18: 2560-6.
17. Giuliano AE, Kirgan DM, Guenther M, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 3: 391-401.
18. Giuliano AE, Barth A, Spivack B, et al. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Sur 1996; 183: 185-9.
19. Giuliano AE. Lymphatic mapping and sentinel node biopsy in breast cancer. JAMA 1997; 277: 791.
20. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection. J Surg Oncol 1996; 62: 75-7.
21. Giuliano AE. Sentinel lymphadenectomy: a new axillary staging procedure of primary breast carcinoma. Breast Dis 1996; 7: 16-7.
22. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 6: 2345-50.
23. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary stoging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
24. Friedman S, Bertin F, Mouriesse H, et al. Importance of tumors cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988; 27: 483-7.
25. International (Ludwig) Breast Cancer. Study Group. Pronostic imptance of occult axillary lymph node metastases from breast cancer. Lancet 1990; 335: 1565-8.
26. Nasser IA, Lee AKC, Bosari S, et al. Occult axillary lymph node metastases in node negative breast carcinoma. Hum Path 1993; 24: 950-7.
27. Turner RR, Ollila DW, Stern S, et al. Optimal histopathological examination of the sentinal lymph node for breast carcinoma staging. Ann Surg Path 1999; 23: 262-7.
28. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node negative breast cancer. Br J Surg 1993; 80: 459-63.
29. Giuliano AE. Prospective observation and study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-9.
30. Garbay JR. Le Ganglion Sentinelle en 2001. La Lettre du Sénologue 2001; n°12: 19-21.
31. Mertz L, Mathelin C, Marin C, et al. Injection sous-aréolaire de sulfocolloïdes technétiés pour l'identification des ganglions sentinelles dans les cancers du sein invasifs à foyers multiples. Bull Cancer 1999; 86: 939-45.
32. Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 1999; 229: 860-5.
33. Smith LF, Cross MJ, Klimberg VS, et al. Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg 2000; 180: 434-8.
34. Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery 2002; 131: 277-86.